New Delhi: The AYUSH Ministry signed an agreement with United States Pharmacopeial Convention (USP) for cooperation in the field of traditional medicines, a move which will also help improve these medicines’ quality.
The Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) under the Ministry signed the MoU with USP which aims at collaborating, identifying, and development and dissemination of science-based standards in this field. “The aim of this historic MoU is to promote the safety, quality and integrity of traditional medicines and botanical dietary supplements,” an official statement said.
The MoU also aims to improve public health in India, US and worldwide by working together to increase awareness and understanding of traditional and herbal medicines, botanical dietary supplements and their products.
Noting that this is a historic deal, AYUSH secretary Ajit Mohan Sharan said it will take forward common cooperation in the field of traditional medicine.
“The MoU will help to harmonize the Pharmacopeia in terms of international conventions. There are one lakh different formulations listed by TDKL and listing them in an understandable and comprehensible form will go a long way in increasing the utility of these formulations internationally,” he said.
PCIM&H is an autonomous organisation under the Ministry with a primary mandate to develop pharmacopoeial standards for drugs and formulations used under AYUSH. “This collaboration will amplify the global public health impact of both organisations by leveraging mutual scientific resources to advance international standards,” said K V Surendranath, senior vice president, Global Sites, USP.
The USP is a global health organisation and its public standards provide scientifically validated test methods and cover over 250 botanical ingredients and dosage forms including ashwagandha, turmeric, turmeric extract and others.